Fem-Pop Stenting - Is Zilver PTX DES the "De Facto" Stent to Deploy? - Krishna Rocha-Singh

↳ This is a section part of Moment: CRT 2017 : CRT ENDOVASCULAR & CLI - SFA Stenting

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Fem-Pop Stenting - Is Zilver PTX DES the "De Facto" Stent to Deploy? - Krishna Rocha-Singh  at CRT 2017.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$8.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

Learning Objectives

Other Components in this Moment

Overview
SFA Intervention - Stenting as Definitive Therapy with New Stent Designs - D. Christopher Metzger
Role of Covered Stents in Long SFA Disease and ISR - Peter Soukas
Fem-Pop Stenting - Is Zilver PTX DES the "De Facto" Stent to Deploy? - Krishna Rocha-Singh
Live case – SFA angioplasty with retrograde pedal access - Lankenau Heart Institute - Philadelphia, PA - William Gray
Loading Simple Education